Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Sara Shalin

Concepts (429)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Skin Neoplasms
34
2024
487
9.380
 Why?
Skin Diseases
7
2022
115
4.010
 Why?
Melanoma
16
2024
281
3.920
 Why?
Dermatology
9
2024
52
3.310
 Why?
Skin
12
2024
417
3.150
 Why?
Immunohistochemistry
18
2024
975
1.950
 Why?
Nevus, Pigmented
3
2024
34
1.930
 Why?
Sebaceous Gland Neoplasms
5
2022
16
1.810
 Why?
Carcinoma, Basal Cell
5
2018
36
1.770
 Why?
Staining and Labeling
3
2021
97
1.610
 Why?
Biopsy
18
2024
592
1.570
 Why?
Adenocarcinoma, Sebaceous
3
2022
7
1.570
 Why?
Nevus, Blue
2
2021
11
1.380
 Why?
Humans
84
2024
50389
1.370
 Why?
Melanocytes
3
2021
38
1.360
 Why?
Neoplasms, Second Primary
2
2024
74
1.270
 Why?
Dermatitis
2
2022
36
1.250
 Why?
Female
47
2024
26981
1.240
 Why?
Erythema Multiforme
2
2020
11
1.190
 Why?
Middle Aged
32
2024
12460
1.110
 Why?
Diagnosis, Differential
14
2024
1042
1.100
 Why?
Aged, 80 and over
18
2024
3180
1.080
 Why?
Vasculitis
2
2024
29
1.060
 Why?
Vulvar Neoplasms
3
2022
58
1.050
 Why?
Alopecia
2
2024
37
1.010
 Why?
Herpes Simplex
2
2022
21
0.990
 Why?
Aged
27
2024
9590
0.960
 Why?
Sebaceous Glands
2
2024
13
0.950
 Why?
Skin Diseases, Vascular
1
2024
9
0.940
 Why?
Incidental Findings
1
2024
39
0.930
 Why?
Dermatitis, Seborrheic
1
2024
3
0.920
 Why?
Neoplasm Staging
2
2024
750
0.920
 Why?
Sweat Gland Neoplasms
3
2024
22
0.920
 Why?
Atrophy
1
2024
38
0.910
 Why?
Sentinel Lymph Node Biopsy
1
2024
118
0.880
 Why?
Adult
24
2024
13568
0.870
 Why?
Nevus, Epithelioid and Spindle Cell
3
2018
15
0.870
 Why?
Papillomavirus Infections
2
2022
168
0.860
 Why?
Hyperoxaluria
1
2022
4
0.840
 Why?
Hyperoxaluria, Primary
1
2022
3
0.840
 Why?
Graft vs Host Disease
2
2020
73
0.840
 Why?
Urolithiasis
1
2022
4
0.840
 Why?
Adenoma
2
2017
112
0.820
 Why?
Pathology
2
2020
38
0.810
 Why?
Epidermal Cyst
1
2022
12
0.810
 Why?
Granuloma
2
2020
45
0.800
 Why?
Carcinoma in Situ
1
2022
73
0.790
 Why?
Protein Kinases
2
2016
70
0.780
 Why?
Muscle, Smooth
1
2021
64
0.770
 Why?
Fungi
1
2021
48
0.750
 Why?
Elastic Tissue
2
2020
10
0.740
 Why?
Artifacts
1
2021
54
0.740
 Why?
Epidermodysplasia Verruciformis
1
2020
2
0.740
 Why?
Foreign Bodies
1
2021
63
0.730
 Why?
Male
32
2024
25718
0.730
 Why?
Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit
1
2020
2
0.730
 Why?
Histiocytoma, Benign Fibrous
1
2020
14
0.720
 Why?
Methenamine
1
2020
1
0.720
 Why?
Periodic Acid-Schiff Reaction
1
2020
2
0.720
 Why?
Lichenoid Eruptions
1
2020
3
0.720
 Why?
Kidney Failure, Chronic
1
2022
200
0.710
 Why?
Vulvar Diseases
1
2020
7
0.710
 Why?
Oncogene Proteins, Fusion
2
2020
59
0.710
 Why?
Uterine Cervical Dysplasia
1
2020
49
0.700
 Why?
Genitalia
1
2020
11
0.700
 Why?
Lichen Sclerosus et Atrophicus
1
2020
7
0.700
 Why?
Lymphatic Metastasis
2
2020
227
0.700
 Why?
Syphilis
1
2020
27
0.690
 Why?
Gynecology
1
2020
49
0.690
 Why?
Lupus Erythematosus, Systemic
1
2020
68
0.680
 Why?
Pseudoxanthoma Elasticum
1
2019
4
0.660
 Why?
Pathology, Surgical
1
2019
18
0.650
 Why?
Fibroma
2
2020
39
0.630
 Why?
Pathology, Clinical
4
2021
24
0.630
 Why?
Telangiectasis
1
2018
3
0.610
 Why?
Receptor Protein-Tyrosine Kinases
1
2018
51
0.600
 Why?
Carcinoma, Squamous Cell
2
2024
325
0.600
 Why?
Carcinoma, Large Cell
1
2017
15
0.590
 Why?
Neoplasms, Multiple Primary
1
2018
43
0.590
 Why?
Carcinoma, Neuroendocrine
1
2017
23
0.590
 Why?
Laryngeal Neoplasms
1
2017
42
0.580
 Why?
Hidrocystoma
1
2017
5
0.580
 Why?
Apocrine Glands
1
2017
7
0.570
 Why?
Calcium Oxalate
1
2017
8
0.570
 Why?
Inflammation
2
2020
608
0.560
 Why?
Young Adult
10
2024
4064
0.550
 Why?
Tumor Suppressor Protein p53
3
2020
214
0.520
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2016
54
0.520
 Why?
Transcription Factors
2
2021
566
0.510
 Why?
Brain Neoplasms
2
2020
288
0.510
 Why?
Carcinoma, Merkel Cell
2
2022
40
0.510
 Why?
Sarcoptes scabiei
1
2015
2
0.500
 Why?
Scabies
1
2015
4
0.490
 Why?
Genital Diseases, Male
1
2015
17
0.480
 Why?
Lymphangioma
1
2014
9
0.480
 Why?
Histiocytosis, Sinus
1
2015
14
0.480
 Why?
Scrotum
1
2015
30
0.480
 Why?
Arm
1
2014
48
0.450
 Why?
Acanthoma
1
2013
2
0.450
 Why?
Fibroadenoma
1
2013
7
0.440
 Why?
Eccrine Glands
1
2013
11
0.440
 Why?
Nuclear Proteins
1
2014
244
0.420
 Why?
Leuprolide
1
2012
2
0.410
 Why?
Mucinosis, Follicular
1
2012
3
0.410
 Why?
Drug Eruptions
1
2012
13
0.410
 Why?
Endometriosis
1
2012
14
0.410
 Why?
Mycosis Fungoides
1
2012
28
0.400
 Why?
Adenocarcinoma, Clear Cell
1
2012
34
0.400
 Why?
Cicatrix
1
2012
43
0.400
 Why?
Antineoplastic Agents, Hormonal
1
2012
49
0.390
 Why?
Thrombosis
1
2015
249
0.390
 Why?
Social Media
3
2018
98
0.380
 Why?
Dermis
2
2021
18
0.370
 Why?
Histones
3
2020
296
0.370
 Why?
Cesarean Section
1
2012
185
0.360
 Why?
Vulva
2
2020
17
0.360
 Why?
Mucous Membrane
2
2020
28
0.350
 Why?
Muir-Torre Syndrome
1
2010
1
0.340
 Why?
Hippocampus
3
2006
220
0.340
 Why?
Gene Rearrangement
2
2021
74
0.330
 Why?
Adolescent
7
2022
6475
0.320
 Why?
Mutation
4
2024
1292
0.300
 Why?
Epithelioid Cells
2
2020
13
0.300
 Why?
Up-Regulation
3
2020
449
0.290
 Why?
Dermatomycoses
2
2016
19
0.270
 Why?
Leukemia, Myeloid, Acute
3
2016
180
0.270
 Why?
Factor XIIIa
2
2016
10
0.270
 Why?
Mutation, Missense
3
2020
104
0.260
 Why?
Neuronal Plasticity
1
2006
56
0.260
 Why?
MAP Kinase Signaling System
1
2006
118
0.250
 Why?
Memory Disorders
1
2006
49
0.250
 Why?
Memory
1
2006
107
0.250
 Why?
Antifungal Agents
3
2016
342
0.250
 Why?
Postoperative Complications
1
2012
1035
0.250
 Why?
Signal Transduction
2
2016
1625
0.240
 Why?
Fluorescent Antibody Technique, Direct
1
2024
3
0.240
 Why?
Nerve Sheath Neoplasms
1
2024
22
0.240
 Why?
Hematopoietic Stem Cell Transplantation
3
2019
555
0.230
 Why?
Neurons
2
2006
455
0.230
 Why?
SOXE Transcription Factors
2
2021
4
0.230
 Why?
MART-1 Antigen
2
2021
12
0.230
 Why?
Mitogen-Activated Protein Kinase 1
1
2004
49
0.230
 Why?
Chickenpox
1
2024
18
0.230
 Why?
Nevus
1
2024
16
0.230
 Why?
Sensitivity and Specificity
2
2024
875
0.220
 Why?
Lymphoma
1
2024
65
0.220
 Why?
Carcinoma
1
2024
139
0.210
 Why?
Fear
1
2004
84
0.210
 Why?
Disease Outbreaks
1
2024
123
0.210
 Why?
Oxalates
1
2022
11
0.210
 Why?
Angioedema
1
2022
9
0.210
 Why?
Demography
1
2022
93
0.200
 Why?
Sarcoidosis
1
2022
44
0.200
 Why?
Rhabdomyosarcoma, Alveolar
1
2022
8
0.200
 Why?
Foot
1
2022
40
0.200
 Why?
Prednisone
1
2022
101
0.200
 Why?
Plant Structures
1
2021
5
0.190
 Why?
Cotton Fiber
1
2021
6
0.190
 Why?
Herpesvirus 2, Human
1
2021
4
0.190
 Why?
Paper
1
2021
15
0.190
 Why?
Lymphokines
1
2021
20
0.190
 Why?
Herpesvirus 1, Human
1
2021
15
0.190
 Why?
Platelet-Derived Growth Factor
1
2021
23
0.190
 Why?
Histocytochemistry
1
2021
47
0.190
 Why?
Dermatofibrosarcoma
1
2021
8
0.190
 Why?
Herpesvirus 3, Human
1
2021
28
0.190
 Why?
Hyperplasia
1
2021
96
0.190
 Why?
Sutures
1
2021
39
0.190
 Why?
Coloring Agents
1
2021
70
0.190
 Why?
Animals
10
2021
13173
0.190
 Why?
Protein Processing, Post-Translational
2
2020
154
0.190
 Why?
Stromal Cells
1
2021
72
0.190
 Why?
Cadherins
2
2019
64
0.190
 Why?
Retrospective Studies
4
2024
6223
0.180
 Why?
Chromones
1
2021
17
0.180
 Why?
Lost to Follow-Up
1
2020
10
0.180
 Why?
Oncogene Fusion
1
2020
4
0.180
 Why?
Gene Expression Regulation, Neoplastic
3
2020
830
0.180
 Why?
DNA-Activated Protein Kinase
1
2021
22
0.180
 Why?
Research Report
1
2020
16
0.180
 Why?
Leprosy, Multibacillary
1
2020
5
0.180
 Why?
Armadillos
1
2020
6
0.180
 Why?
Skin Transplantation
1
2021
43
0.180
 Why?
S100 Proteins
2
2021
34
0.180
 Why?
Morpholines
1
2021
66
0.180
 Why?
Histiocytes
1
2020
10
0.180
 Why?
Neoplasms, Fibrous Tissue
1
2020
2
0.180
 Why?
Phagocytosis
1
2020
49
0.170
 Why?
Germ Cells
1
2020
12
0.170
 Why?
Lymphocytes, Tumor-Infiltrating
2
2018
75
0.170
 Why?
Ubiquitin-Protein Ligases
1
2021
93
0.170
 Why?
Graft Survival
1
2021
153
0.170
 Why?
Papillomaviridae
1
2020
103
0.170
 Why?
Matrix Metalloproteinase 2
1
2020
58
0.170
 Why?
Li-Fraumeni Syndrome
1
2020
12
0.170
 Why?
Immunotherapy
2
2019
235
0.170
 Why?
Single-Cell Analysis
1
2020
63
0.170
 Why?
Matrix Metalloproteinase 9
1
2020
87
0.170
 Why?
Graft Rejection
1
2021
168
0.170
 Why?
Adenocarcinoma
1
2024
402
0.170
 Why?
Consensus
1
2020
159
0.170
 Why?
Proto-Oncogene Proteins B-raf
2
2017
78
0.170
 Why?
Elastin
1
2019
23
0.160
 Why?
Integrin alpha Chains
1
2019
9
0.160
 Why?
Intracranial Arteriovenous Malformations
1
2019
30
0.160
 Why?
Disease Progression
3
2020
823
0.160
 Why?
Cell Cycle Checkpoints
1
2019
30
0.160
 Why?
Child
4
2022
6877
0.160
 Why?
Melanoma, Experimental
1
2019
40
0.160
 Why?
Arteriovenous Malformations
1
2019
68
0.150
 Why?
DNA-Binding Proteins
1
2021
424
0.150
 Why?
Acute Disease
1
2019
370
0.150
 Why?
Collagen
1
2019
208
0.150
 Why?
Cricoid Cartilage
1
2017
11
0.150
 Why?
Proto-Oncogene Proteins c-kit
1
2017
36
0.150
 Why?
Antigens, CD
1
2019
216
0.140
 Why?
Dilatation
1
2017
26
0.140
 Why?
T-Lymphocytes, Regulatory
1
2018
82
0.140
 Why?
Tumor Burden
1
2017
131
0.140
 Why?
Practice Guidelines as Topic
1
2020
460
0.140
 Why?
Connective Tissue Diseases
1
2017
16
0.140
 Why?
Tumor Escape
1
2017
16
0.140
 Why?
Parvoviridae Infections
1
2017
20
0.140
 Why?
Immunologic Surveillance
1
2017
10
0.140
 Why?
Parvovirus B19, Human
1
2017
17
0.140
 Why?
CTLA-4 Antigen
1
2017
23
0.140
 Why?
Histone Code
1
2017
30
0.140
 Why?
Rhizopus
1
2016
4
0.140
 Why?
Trachea
1
2017
52
0.140
 Why?
Sarcoma
1
2018
66
0.140
 Why?
Programmed Cell Death 1 Receptor
1
2017
40
0.140
 Why?
RNA, Fungal
1
2016
21
0.140
 Why?
Mucormycosis
1
2016
29
0.140
 Why?
Connexins
1
2016
25
0.140
 Why?
Splenomegaly
1
2016
11
0.140
 Why?
Ascomycota
1
2016
9
0.140
 Why?
Angiomyoma
1
2016
5
0.140
 Why?
Infant
2
2015
3601
0.130
 Why?
Mice
6
2021
5688
0.130
 Why?
Osteosarcoma
1
2016
45
0.130
 Why?
Apoptosis
3
2019
1094
0.130
 Why?
Antineoplastic Agents, Alkylating
1
2016
74
0.130
 Why?
Recurrence
2
2015
664
0.130
 Why?
Human Growth Hormone
1
2016
50
0.130
 Why?
Candidiasis
1
2016
114
0.130
 Why?
Lung Neoplasms
2
2019
600
0.130
 Why?
Education, Medical, Continuing
1
2016
68
0.130
 Why?
Cell Transformation, Neoplastic
1
2016
181
0.130
 Why?
Dendritic Cells
1
2016
133
0.130
 Why?
Adipocytes
1
2016
121
0.120
 Why?
Avoidance Learning
2
2006
16
0.120
 Why?
Hamartoma Syndrome, Multiple
1
2015
15
0.120
 Why?
Fibrin
1
2015
10
0.120
 Why?
Neoplastic Syndromes, Hereditary
1
2015
16
0.120
 Why?
Lysine
1
2015
83
0.120
 Why?
Facial Neoplasms
1
2015
22
0.120
 Why?
WT1 Proteins
1
2014
4
0.120
 Why?
Pigmentation Disorders
1
2014
6
0.120
 Why?
Carcinosarcoma
1
2015
18
0.120
 Why?
Osteomyelitis
1
2016
125
0.120
 Why?
Purpura
1
2014
7
0.120
 Why?
Keratin-20
1
2014
7
0.120
 Why?
United States
2
2022
4913
0.120
 Why?
Herpes Zoster
1
2014
13
0.120
 Why?
Hemangiosarcoma
1
2014
16
0.120
 Why?
Eosinophils
1
2015
41
0.120
 Why?
Drug Resistance, Neoplasm
1
2017
318
0.120
 Why?
Fellowships and Scholarships
1
2016
118
0.120
 Why?
Loss of Heterozygosity
1
2015
77
0.120
 Why?
Patient Education as Topic
1
2018
317
0.120
 Why?
Churg-Strauss Syndrome
1
2014
3
0.120
 Why?
Prospective Studies
1
2020
2414
0.120
 Why?
Tumor Suppressor Proteins
1
2015
127
0.120
 Why?
DNA Copy Number Variations
1
2015
109
0.120
 Why?
Mass Spectrometry
1
2015
284
0.120
 Why?
Antigens, CD34
1
2014
65
0.120
 Why?
Lymphocytes
1
2015
154
0.110
 Why?
Exanthema
1
2014
31
0.110
 Why?
Neoplasm Proteins
1
2016
321
0.110
 Why?
Eosinophilia
1
2014
36
0.110
 Why?
Neutrophils
1
2015
148
0.110
 Why?
Sarcoma, Kaposi
1
2014
75
0.110
 Why?
Membrane Glycoproteins
1
2014
244
0.110
 Why?
Chromosome Aberrations
1
2015
295
0.110
 Why?
Antibodies, Monoclonal
1
2017
462
0.110
 Why?
Kaplan-Meier Estimate
3
2020
466
0.110
 Why?
Head and Neck Neoplasms
1
2016
282
0.100
 Why?
Prognosis
4
2019
1979
0.100
 Why?
Proteasome Endopeptidase Complex
1
2013
116
0.100
 Why?
DNA Mismatch Repair
1
2012
16
0.100
 Why?
Treatment Outcome
5
2021
5230
0.100
 Why?
Cell Differentiation
1
2014
651
0.100
 Why?
Predictive Value of Tests
1
2014
934
0.100
 Why?
Multiple Myeloma
2
2016
2949
0.090
 Why?
Asthma
1
2014
282
0.090
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2016
578
0.080
 Why?
Fatal Outcome
2
2022
195
0.080
 Why?
CD8-Positive T-Lymphocytes
2
2019
123
0.070
 Why?
Phorbol Esters
1
2006
3
0.070
 Why?
Association Learning
1
2006
11
0.070
 Why?
Theta Rhythm
1
2006
10
0.070
 Why?
Amphotericin B
2
2016
109
0.070
 Why?
Child, Preschool
1
2015
3908
0.070
 Why?
Maze Learning
1
2006
32
0.070
 Why?
Mice, Mutant Strains
1
2006
71
0.070
 Why?
Isoproterenol
1
2006
56
0.070
 Why?
Adrenergic beta-Agonists
1
2006
41
0.070
 Why?
Protein Kinase C
1
2006
70
0.070
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2006
81
0.060
 Why?
Immunocompromised Host
2
2016
119
0.060
 Why?
Neoplasm Metastasis
2
2016
235
0.060
 Why?
Cell Proliferation
2
2019
989
0.060
 Why?
T-Lymphocytes
2
2017
331
0.060
 Why?
Time Factors
2
2016
2934
0.060
 Why?
Nerve Growth Factor
1
2004
13
0.060
 Why?
Superior Cervical Ganglion
1
2004
7
0.060
 Why?
Disease Notification
1
2024
10
0.060
 Why?
Sensory Thresholds
1
2004
16
0.060
 Why?
Blotting, Southern
1
2004
43
0.060
 Why?
Intellectual Disability
1
2006
128
0.060
 Why?
Exploratory Behavior
1
2004
23
0.060
 Why?
Mitogen-Activated Protein Kinase 3
1
2004
48
0.060
 Why?
Luminescent Proteins
1
2004
55
0.060
 Why?
Green Fluorescent Proteins
1
2004
92
0.060
 Why?
Shock
1
2004
34
0.060
 Why?
Proto-Oncogene Proteins p21(ras)
1
2024
66
0.060
 Why?
Physician's Role
1
2024
48
0.060
 Why?
Brain
2
2019
1313
0.050
 Why?
Mitogen-Activated Protein Kinases
1
2004
154
0.050
 Why?
Psychomotor Performance
1
2004
123
0.050
 Why?
Animals, Newborn
1
2004
367
0.050
 Why?
Behavior, Animal
1
2004
176
0.050
 Why?
Motor Activity
1
2004
222
0.050
 Why?
Blotting, Western
1
2004
587
0.050
 Why?
Eyelids
1
2022
29
0.050
 Why?
Mice, Transgenic
1
2004
543
0.050
 Why?
Desmin
1
2022
6
0.050
 Why?
Edema
1
2022
68
0.050
 Why?
Follow-Up Studies
2
2020
2219
0.050
 Why?
Gene Expression
1
2004
613
0.050
 Why?
gp100 Melanoma Antigen
1
2021
8
0.050
 Why?
Microphthalmia-Associated Transcription Factor
1
2021
4
0.050
 Why?
DNA, Viral
1
2021
133
0.050
 Why?
Mycobacterium leprae
1
2020
8
0.050
 Why?
Soil Microbiology
1
2020
19
0.040
 Why?
In Situ Hybridization, Fluorescence
1
2021
256
0.040
 Why?
RNA, Messenger
1
2004
1101
0.040
 Why?
Dose-Response Relationship, Drug
1
2004
1356
0.040
 Why?
Societies, Medical
1
2021
179
0.040
 Why?
Retinoblastoma Protein
1
2020
18
0.040
 Why?
Indoleamine-Pyrrole 2,3,-Dioxygenase
1
2020
16
0.040
 Why?
Mice, Inbred BALB C
1
2021
297
0.040
 Why?
Cells, Cultured
1
2004
1589
0.040
 Why?
Evidence-Based Medicine
1
2021
249
0.040
 Why?
Rats, Sprague-Dawley
1
2004
1582
0.040
 Why?
Ulcer
1
2020
23
0.040
 Why?
Radiotherapy, Adjuvant
1
2020
60
0.040
 Why?
Antiviral Agents
1
2021
168
0.040
 Why?
Host-Pathogen Interactions
1
2021
136
0.040
 Why?
Germ-Line Mutation
1
2020
63
0.040
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2020
60
0.040
 Why?
Malpractice
1
2019
15
0.040
 Why?
Linear Models
1
2020
279
0.040
 Why?
Microcirculation
1
2019
72
0.040
 Why?
Diagnostic Errors
1
2019
66
0.040
 Why?
Proportional Hazards Models
1
2020
418
0.040
 Why?
Multivariate Analysis
1
2020
583
0.040
 Why?
Fibrosis
1
2019
179
0.040
 Why?
Survival Analysis
1
2020
671
0.040
 Why?
Flow Cytometry
1
2021
475
0.040
 Why?
Tumor Cells, Cultured
1
2019
462
0.040
 Why?
Transcriptome
1
2020
316
0.040
 Why?
Rare Diseases
1
2018
43
0.040
 Why?
Rats
1
2004
3287
0.040
 Why?
Larynx
1
2017
30
0.040
 Why?
Cadaver
1
2017
96
0.040
 Why?
Pressure
1
2017
105
0.040
 Why?
Forkhead Transcription Factors
1
2018
110
0.040
 Why?
Immunomodulation
1
2017
36
0.030
 Why?
Tumor Microenvironment
1
2019
223
0.030
 Why?
Genetic Predisposition to Disease
1
2020
509
0.030
 Why?
Forearm
1
2016
28
0.030
 Why?
Debridement
1
2016
45
0.030
 Why?
Epithelial-Mesenchymal Transition
1
2017
49
0.030
 Why?
Pilot Projects
1
2019
704
0.030
 Why?
Blood Cell Count
1
2016
38
0.030
 Why?
Toes
1
2016
14
0.030
 Why?
Induction Chemotherapy
1
2016
60
0.030
 Why?
Disease-Free Survival
1
2017
450
0.030
 Why?
Lymphocyte Activation
1
2017
172
0.030
 Why?
Family
1
2018
176
0.030
 Why?
Antibiotic Prophylaxis
1
2016
61
0.030
 Why?
Treatment Refusal
1
2016
35
0.030
 Why?
Abscess
1
2016
40
0.030
 Why?
Chemotherapy, Adjuvant
1
2016
121
0.030
 Why?
Triazoles
1
2016
112
0.030
 Why?
Cell Movement
1
2017
246
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2016
181
0.030
 Why?
Biopsy, Needle
1
2016
182
0.030
 Why?
Core Binding Factor Alpha 1 Subunit
1
2015
43
0.030
 Why?
Epigenomics
1
2016
67
0.030
 Why?
Disease Models, Animal
1
2021
1419
0.030
 Why?
Methylation
1
2015
118
0.030
 Why?
Mice, Inbred C57BL
1
2021
1785
0.030
 Why?
Polymerase Chain Reaction
1
2016
456
0.030
 Why?
Proteome
1
2017
159
0.030
 Why?
Pedigree
1
2015
125
0.030
 Why?
Comparative Genomic Hybridization
1
2015
46
0.030
 Why?
Scalp
1
2015
43
0.030
 Why?
Transplantation, Autologous
1
2016
464
0.030
 Why?
Arkansas
1
2020
1991
0.030
 Why?
Bone Marrow
1
2016
356
0.030
 Why?
Hyperlipidemias
1
2014
52
0.030
 Why?
DNA Mutational Analysis
1
2015
176
0.030
 Why?
Reoperation
1
2016
457
0.030
 Why?
Respiratory Function Tests
1
2014
88
0.030
 Why?
Lipodystrophy
1
2013
9
0.030
 Why?
Heterozygote
1
2013
83
0.030
 Why?
Incidence
1
2016
1017
0.030
 Why?
Muscular Atrophy
1
2013
71
0.030
 Why?
Syndrome
1
2013
239
0.030
 Why?
Neoplasm Recurrence, Local
1
2016
634
0.030
 Why?
Epigenesis, Genetic
1
2015
374
0.020
 Why?
Risk Assessment
1
2016
1258
0.020
 Why?
Cell Line, Tumor
1
2015
1399
0.020
 Why?
Severity of Illness Index
1
2014
963
0.020
 Why?
Magnetic Resonance Imaging
1
2016
1534
0.020
 Why?
Tomography, X-Ray Computed
1
2014
1160
0.020
 Why?
Antineoplastic Agents
1
2016
1178
0.020
 Why?
Shalin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (429) concept(s)
_
Co-Authors Expand Description
See all (33) people
_
Same Department Expand Description
Search Department